Results
1 -
10 of
57
(Click
here to explore results)
Designing Multi-Target Drugs, Chapter 11 Combination Agents Versus Multi-Targeted Agents – Pros and Cons . Jose G. Monzon, Janet Dancey
, 2012
, Pages 155-180
Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 11 LRRK2 Kinase Inhibitors as New Drugs for Parkinson’s Disease? . Sandra Schulz, Stefan Göring, Boris Schmidt, Carsten Hopf
, 2013
, Pages 266-293
Kinase Drug Discovery, Chapter 5 Kinase Mutations and Resistance in Cancer . Jack Andrew Bikker
, 2012
, Pages 126-160
Kinase Drug Discovery: Modern Approaches, CHAPTER 11 The Importance of Kinase Mutations in Cancer Drug Discovery . Richard A. Ward, Frederick W. Goldberg
, 2019
, Pages 281-312
Kinase Drug Discovery, Chapter 3 The Learning and Evolution of Medicinal Chemistry against Kinase Targets . Martin E. Swarbrick
, 2012
, Pages 79-95
Drug Transporters: Volume 2: Recent Advances and Emerging Technologies, Chapter 5 Pharmacogenomics of Drug Transporters: Clinical Implications . Ichiro Ieiri
, 2016
, Volume 2
, Pages 114-142
Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets . Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 13 Hsp90 Inhibitors in Clinic . Emin Avsar
, 2014
, Pages 336-378
Nanogels for Biomedical Applications, Chapter 13 Future of Nanogels for Sensing Applications . Pandiaraj Manickam, Michelle Pierre, Rahul Dev Jayant, Madhavan Nair, Shekhar Bhansali
, 2018
, Pages 261-282
Kinase Drug Discovery: Modern Approaches, CHAPTER 10 Drugging the Kinome . A. D. Axtman, R. Couñago, D. H. Drewry, M. B. Robers, C. I. Wells
, 2019
, Pages 253-280